Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 135.84M | 149.61M | 136.58M | 101.91M | 91.84M | 86.86M |
Gross Profit | 81.64M | 96.15M | 94.70M | 95.17M | 88.41M | 78.63M |
EBITDA | 16.12M | 32.10M | 34.30M | 39.91M | 37.26M | 28.13M |
Net Income | 11.21M | 23.67M | 25.00M | 28.78M | 26.43M | 19.26M |
Balance Sheet | ||||||
Total Assets | 2.85B | 2.78B | 2.71B | 2.65B | 2.42B | 2.28B |
Cash, Cash Equivalents and Short-Term Investments | 323.16M | 468.77M | 620.84M | 688.46M | 819.01M | 663.15M |
Total Debt | 108.08M | 118.52M | 40.80M | 105.76M | 25.54M | 11.11M |
Total Liabilities | 2.62B | 2.56B | 2.52B | 2.48B | 2.21B | 2.08B |
Stockholders Equity | 234.97M | 215.31M | 195.24M | 166.39M | 211.46M | 199.70M |
Cash Flow | ||||||
Free Cash Flow | 29.11M | 26.19M | 30.42M | 34.62M | 35.09M | 27.79M |
Operating Cash Flow | 32.32M | 29.82M | 30.88M | 35.05M | 35.46M | 28.66M |
Investing Cash Flow | 152.98M | -57.72M | -82.38M | -252.62M | -242.48M | -495.85M |
Financing Cash Flow | 64.54M | 38.10M | 32.48M | 246.46M | 125.47M | 453.82M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | $227.66M | 10.75 | 8.28% | 5.48% | 14.84% | 169.99% | |
76 Outperform | ― | ― | 14.11% | 29.41% | |||
76 Outperform | $244.78M | 13.50 | 8.60% | 2.84% | 7.42% | 15.82% | |
72 Outperform | $250.61M | 22.05 | 5.18% | 2.41% | -6.64% | -51.99% | |
68 Neutral | $17.80B | 11.94 | 9.89% | 3.74% | 9.69% | 1.17% | |
60 Neutral | ― | ― | -6.85% | -51.70% | |||
57 Neutral | $275.26M | 93.08 | 0.79% | 3.58% | 4.72% | ― |
In September 2025, Chemung Financial Corporation’s management plans to engage with institutional investors to discuss strategies and performance. The company has recently undertaken significant financial restructuring, including issuing $45 million in subordinated notes and selling $245.5 million in securities, resulting in a $17.5 million pre-tax loss. These moves aim to optimize the balance sheet, enhance profitability, and support growth strategies, potentially impacting stakeholders positively by improving capital ratios and expanding market presence.
On August 19, 2025, Chemung Financial Corporation announced a dividend increase of $0.02 per share, resulting in a quarterly cash dividend of $0.34 per share, payable on October 1, 2025, to shareholders of record as of September 17, 2025. This marks the second dividend increase in 2025, representing a 6.3% rise over the previous quarter’s dividend and bringing the total increase for the year to 9.7%.
Chemung Financial Corporation announced its participation in the 2025 KBW Community Bank Investor Conference, where management will meet with institutional investors to discuss strategies and recent financial performance. The company highlighted its stable deposit base, strategic balance sheet restructuring, and expansion into higher growth markets like Albany and Buffalo. Recent financial activities include issuing $45 million in subordinated notes and selling $245.5 million in securities, resulting in a $17.5 million pre-tax loss. These moves are expected to enhance profitability metrics and support capital ratios, reflecting a strategic focus on growth and operational efficiency.
Chemung Financial Corporation announced the completion of a strategic balance sheet repositioning by selling securities worth approximately $242 million, resulting in a pre-tax loss of $17 million to be recognized in the second quarter of 2025. The proceeds will be used to reduce non-core funding liabilities and support loan growth, with expectations of improved financial metrics from the third quarter of 2025, despite reporting a net loss for the second quarter.
On June 10, 2025, Chemung Financial Corporation issued $45 million in subordinated notes due 2035 to accredited investors and institutional buyers. This move aims to support the company’s growth initiatives and regulatory capital ratios, potentially involving balance sheet restructuring. The notes, maturing in 2035, will initially bear a fixed interest rate of 7.75% until 2030, after which they will switch to a floating rate. This strategic financial maneuver is expected to enhance Chemung’s capital structure and support its expansion efforts.